France
4
2017-11-30
4
2019-12-31
These are the the leading inventors for applications assigned to Inserm:
Inserm based in , FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Selective Nox-1 inhibitor peptides and uses thereof
#2 | 2012-06-26 ✅ Patent 8,207,137 granted on 2012-06-26Method of inhibiting angiogenesis or invasion or formation of metastases
#3 | 2012-02-21 ✅ Patent 8,119,609 granted on 2012-02-21Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors
#4 | 2006-08-03 ✅ Patent 7,531,622 granted on 2009-05-12Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells
415664 ⎘